Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHH-1V Booster Vaccination in COVID-19 Vaccinated Adults
NCT05246137Phase 3Completed
- Sponsor
- HIPRA
- Start
- Feb 2022
- Primary completion
- Mar 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of PHH-1V in coronavirus disease 2019 (COVID-19), sponsored by HIPRA. Started Feb 2022; status: completed.
02
Drugs
PHH-1V
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05246137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05246137.